Ana Bacic, ARNP (she/her/hers)

Gilead Sciences, Inc.

Poster(s):

• P3856 - Elevations in Total Serum Bile Acids During Bulevirtide Treatment Show No Association With Adverse Events of Interest in Patients With Chronic Hepatitis Delta: An Integrated Safety Analysis of 48-Week Data
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT